MDLinx Psychiatry5 minutes to stay current |
|
American Journal of Psychiatry, 04/08/14
Voican CS, et al. – The authors review clinical data relevant to antidepressant–induced liver injury and provide recommendations for clinical practice. Although an infrequent event, DILI from antidepressant drugs may be irreversible, and clinicians should be aware of it. Aminotransferase surveillance is the most useful tool for detecting DILI, and prompt discontinuation of the drug responsible is essential. The results of antidepressant liver toxicity in all phases of clinical trials should be available and published. Further research is needed before any new and rigorously founded recommendations can be made.
Affective disorders and risk of developing dementia: systematic review
The British Journal of Psychiatry, 03/04/13
da Silva J et al. - The study aims to evaluate the risk of developing dementia in individuals with a history of affective disorder. Affective disorders appear to be associated with an increased risk of developing dementia, and one that is dependent on clinical and demographic variables. Depression may be both a prodrome and a risk factor for dementia.
Selective serotonin reuptake inhibitor drug interactions in patients receiving statins
The Journal of Clinical Psychiatry, 03/05/14
Andrade C – Elderly patients commonly receive statin drugs for the primary or secondary prevention of cardiovascular and cerebrovascular events. Elderly patients also commonly receive antidepressant drugs, usually selective serotonin reuptake inhibitors (SSRIs), for the treatment of depression, anxiety, or other conditions. SSRIs are associated with many pharmacokinetic drug interactions related to the inhibition of the cytochrome P450 (CYP) metabolic pathways.
Metabolic Syndrome and Metabolic Abnormalities in Bipolar Disorder: A Meta-Analysis of Prevalence Rates and Moderators
American Journal of Psychiatry, 03/04/13
Vancampfort D et al. – The authors sought to clarify the prevalence and moderators of metabolic syndrome in bipolar patients, accounting for subgroup differences. The findings strongly support the claim that patients with bipolar disorder are at high risk for metabolic syndrome and related cardiovascular morbidity and mortality and require regular monitoring and adequate preventive efforts and treatment for cardio–metabolic risk factors. These findings further suggest that the risk of metabolic syndrome is greater in bipolar patients taking prescribed antipsychotic medication.
Receive more summaries like this by joining MDLinx. We provide free daily digests of top journal articles in your field. >> Click here to choose your specialties.
Other articles in Psychiatry
>> Click here to see the complete list
Effects of Gingko biloba supplementation in Alzheimer's
disease patients receiving cholinesterase inhibitors: Data from the
ICTUS study
Phytomedicine, 03/11/14
Phytomedicine, 03/11/14
Antidementia drug use among community-dwelling individuals
with Alzheimers disease in Finland: a nationwide register-based study
International Clinical Psychopharmacology, 03/10/14
International Clinical Psychopharmacology, 03/10/14
The treatment of Alzheimer's disease using Chinese Medicinal
Plants: From disease models to potential clinical applications
Journal of Ethnopharmacology , 03/14/14
Journal of Ethnopharmacology , 03/14/14
Vitamin D supplementation for depressive symptoms: a
systematic review and meta-analysis of randomized controlled trials
Psychosomatic Medicine, 03/19/14
Psychosomatic Medicine, 03/19/14
Opioids compared with placebo or other treatments for chronic
low back pain: An update of the cochrane review
Spine, 03/28/14
Spine, 03/28/14
Mindfulness-based cognitive therapy (MBCT) versus the
health-enhancement program (HEP) for adults with treatment-resistant
depression: a randomized control trial study protocol
BMC Complementary and Alternative Medicine, 03/11/14
BMC Complementary and Alternative Medicine, 03/11/14
Effect of omega-3 fatty acid supplementation on cancer
incidence, non-vascular death, and total mortality: a meta-analysis of
randomized controlled trials
BMC Public Health, 03/05/14
BMC Public Health, 03/05/14
Tremor
JAMA, 03/06/14
JAMA, 03/06/14
The effect of L-thyroxine substitution on lipid profile,
glucose homeostasis, inflammation and coagulation in patients with
subclinical hypothyroidism
International Journal of Clinical Practice, 03/12/14
International Journal of Clinical Practice, 03/12/14
Alterations in brain temperatures as a possible cause of migraine headache
Medical Hypotheses, 03/10/14
Medical Hypotheses, 03/10/14
Multicenter phase IV study of palonosetron in the prevention
of chemotherapy-induced nausea and vomiting (CINV) in patients with
non-Hodgkin lymphomas undergoing repeated cycles of moderately
emetogenic chemotherapy
Leukemia and Lymphoma, 03/05/14
Leukemia and Lymphoma, 03/05/14
Effect of sertraline on risk of falling in older adults with
psychotic depression on olanzapine: Results of a randomized
placebo-controlled trial
The American Journal of Geriatric Psychiatry, 03/17/14
The American Journal of Geriatric Psychiatry, 03/17/14
Brain regions associated with risk and resistance for bipolar
I disorder: A voxel-based MRI study of patients with bipolar disorder
and their healthy siblings
Bipolar Disorders, 03/05/14
Bipolar Disorders, 03/05/14
Celecoxib: a new augmentation strategy for depressive mood
episodes. A systematic review and meta-analysis of randomized
placebo-controlled trials
Human Psychopharmacology: Clinical and Experimental, 03/31/14
Human Psychopharmacology: Clinical and Experimental, 03/31/14
No comments:
Post a Comment